Erythropoietin Drugs Market Estimated to Reach USD 14.3 billion, Advancing at a CAGR of 3.8% by 2034: Transparency Market Research Inc.
September 18, 2024 07:05 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The global erythropoietin drugs market is estimated to surge at a CAGR of 3.8% from 2024...
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
September 04, 2023 05:37 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
September 04, 2023 05:34 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Erythropoietin Drugs Market Value Predicted To Reach US$ 14.2 Billion By 2027 Covering COVID-19 Impact: Acumen Research and Consulting
June 21, 2021 12:44 ET
|
Acumen Research and Consulting
LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- The Global Erythropoietin Drugs Market is expected to grow at a CAGR of around 5.8% from 2020 to 2027 and reach the market value of over US$ 14.2 Bn by...